Surgical and Interventional Therapies for Pulmonary Arterial Hypertension

ABSTRACT

Surgical and interventional therapies for pulmonary arterial hypertension (PAH) in appropriately selected patients have the potential to dramatically improve or, in some cases, cure PAH. These include atrial septostomy, a palliative procedure or bridge to transplantation in patients with refractory right heart failure, pulmonary thromboendarterectomy for pulmonary hypertension associated with chronic thromboembolic disease, and closure of congenital systemic-pulmonary shunts in patients with PAH but without significant pulmonary vascular disease. Lung transplantation should be considered for patients with all forms of PAH who demonstrate advanced or progressive disease.

KEYWORDS

Pulmonary arterial hypertension - congenital heart disease - pulmonary thromboendarterectomy - lung and heart-lung transplantation - atrial septostomy

REFERENCES

• 1 Kerstein D, Levy P S, Hsu D T, Hordof A J, Gersony W M, Barst R J. Blade balloon atrial septogstomy in patients with severe primary pulmonary hypertension.  Circulation. 1995;  91 2028-2035
• 2 Allcock R J, O'Sullivan J J, Corris P A. Atrial septostomy for pulmonary arterial hypertension.  Heart. 2003;  89 1344-1347
• 3 Rich S, Dodin E, McLaughlin V V. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application.  Am J Cardiol. 1997;  80 369-371
• 4 Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro L M. Atrial septostomy in the treatment of severe pulmonary arterial hypertension.  Thorax. 2003;  58 797-800
• 5 Rothman A, Sklansky M S, Lucas V W et al.. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension.  Am J Cardiol. 1999;  84 682-686
• 6 Khan M A, Bricker J T, Mullins C E, Yousef S A, Nihill M R, Vargo T A. Blade atrial septostomy: experience with the first 50 procedures.  Cathet Cardiovasc Diagn. 1991;  23 257-262
• 7 Sandoval J, Gaspar J, Pulido T et al.. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment.  J Am Coll Cardiol. 1998;  32 297-304
• 8 Barst R J. Role of atrial septostomy in the treatment of pulmonary vascular disease.  Thorax. 2000;  55 95-96
• 9 Pengo V, Lensing A W, Prins M H et al.. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.  N Engl J Med. 2004;  350 2257-2264
• 10 Daily P O, Dembitsky W P, Jamieson S W. The evolution and the current state of the art of pulmonary thromboendarterectomy.  Semin Thorac Cardiovasc Surg. 1999;  11 152-163
• 11 Fishman A J, Moser K M, Fedullo P F. Perfusion lung scans vs pulmonary angiography in evaluation of suspected primary pulmonary hypertension.  Chest. 1983;  84 679-683
• 12 Ryan K L, Fedullo P F, Davis G B, Vasquez T E, Moser K M. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension.  Chest. 1988;  93 1180-1185
• 13 Auger W R, Fedullo P F, Moser K M, Buchbinder M, Peterson K L. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.  Radiology. 1992;  182 393-398
• 14 Straube K R, Dotter C T, O'Dell J. Death following selective right ventricular angiocardiography: a case report.  Radiology. 1963;  80 616-621
• 15 Watson H. Severe pulmonary hypertensive episodes following angiocardiography with sodium metrizoate.  Lancet. 1964;  171 732-733
• 16 Mills S R, Jackson D C, Older R A, Heaston D K, Moore A V. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series.  Radiology. 1980;  136 295-299
• 17 Nicod P, Peterson K, Levine M et al.. Pulmonary angiography in severe chronic pulmonary hypertension.  Ann Intern Med. 1987;  107 565-568
• 18 Hofmann L V, Lee D S, Gupta A et al.. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience.  AJR Am J Roentgenol. 2004;  183 779-786
• 19 Pitton M B, Duber C, Mayer E, Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension.  Circulation. 1996;  94 2485-2491
• 20 Tardivon A A, Musset D, Maitre S et al.. Role of CT in chronic pulmonary embolism: comparison with pulmonary angiography.  J Comput Assist Tomogr. 1993;  17 345-351
• 21 Bergin C J, Sirlin C B, Hauschildt J P et al.. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation.  Radiology. 1997;  204 695-702
• 22 Ley S, Kauczor H U, Heussel C P et al.. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension.  Eur Radiol. 2003;  13 2365-2371
• 23 Kreitner K F, Ley S, Kauczor H U et al.. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.  Radiology. 2004;  232 535-543
• 24 Moser K M, Auger W R, Fedullo P F. Chronic major-vessel thromboembolic pulmonary hypertension.  Circulation. 1990;  81 1735-1743
• 25 Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schafers H J. Pulmonary thromboendarterectomy: risk factors for early survival and hemodynamic improvement.  Eur J Cardiothorac Surg. 2001;  19 771-776
• 26 Gilbert T B, Gaine S P, Rubin L J, Sequeira A J. Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy.  World J Surg. 1998;  22 1029-1032 discussion 33
• 27 Barzaghi N, Maurelli M, Emmi V et al.. Pulmonary thromboendarterectomy in a patient with cryoagglutinins.  J Cardiothorac Vasc Anesth. 2000;  14 447-448
• 28 Yung G L, Channick R N, Fedullo P F et al.. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease.  Am J Respir Crit Care Med. 1998;  157(5 Pt 1) 1690-1693
• 29 Jamieson S W, Auger W R, Fedullo P F et al.. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period.  J Thorac Cardiovasc Surg. 1993;  106 116-126 discussion 26-27
• 30 Moser K M, Spragg R G, Utley J, Daily P O. Chronic thrombotic obstruction of major pulmonary arteries: results of thromboendarterectomy in 15 patients.  Ann Intern Med. 1983;  99 299-304
• 31 Ando M, Okita Y, Tagusari O, Kitamura S, Nakanishi N, Kyotani S. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients.  J Card Surg. 1999;  14 377-385
• 32 Menzel T, Wagner S, Kramm T et al.. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy.  Chest. 2000;  118 897-903
• 33 Kapitan K S, Clausen J L, Moser K M. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy.  Chest. 1990;  98 14-19
• 34 Moser K M, Auger W R, Fedullo P F, Jamieson S W. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment.  Eur Respir J. 1992;  5 334-342
• 35 Chitwood Jr W R, Sabiston Jr D C, Wechsler A S. Surgical treatment of chronic unresolved pulmonary embolism.  Clin Chest Med. 1984;  5 507-536
• 36 Mayer E, Kramm T, Dahm M et al.. Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.  Z Kardiol. 1997;  86 920-927
• 37 Miller Jr W T, Osiason A W, Langlotz C P, Palevsky H I. Reperfusion edema after thromboendarterectomy: radiographic patterns of disease.  J Thorac Imaging. 1998;  13 178-183
• 38 Auger W, Fedullo P F, Moser K. In-hospiral mortality has decreased for patients undergoing pulmonary thromboendarterectomy [abstract].  Am J Respir Crit Care Med. 1996;  153 A92
• 39 Kerr K M, Auger W R, Marsh J J et al.. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.  Am J Respir Crit Care Med. 2000;  162 14-20
• 40 Mares P, Gilbert T B, Tschernko E M et al.. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies.  Anesth Analg. 2000;  90 267-273
• 41 Archibald C J, Auger W R, Fedullo P F et al.. Long-term outcome after pulmonary thromboendarterectomy.  Am J Respir Crit Care Med. 1999;  160 523-528
• 42 Mo M, Kapelanski D P, Mitruka S N et al.. Reoperative pulmonary thromboendarterectomy.  Ann Thorac Surg. 1999;  68 1770-1776 discussion 6-7
• 43 Feinstein J A, Goldhaber S Z, Lock J E, Ferndandes S M, Landzberg M J. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.  Circulation. 2001;  103 10-13
• 44 Reitz B A, Wallwork J L, Hunt S A et al.. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.  N Engl J Med. 1982;  306 557-564
• 45 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004.  J Heart Lung Transplant. 2004;  23 804-815
• 46 D'Alonzo G E, Barst R J, Ayres S M et al.. Survival in patients with primary pulmonary hypertension: results from a national prospective registry.  Ann Intern Med. 1991;  115 343-349
• 47 Shapiro S M, Oudiz R J, Cao T et al.. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.  J Am Coll Cardiol. 1997;  30 343-349
• 48 McLaughlin V V, Genthner D E, Panella M M, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.  N Engl J Med. 1998;  338 273-277
• 49 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  Transplantation. 1998;  66 951-956
• 50 Hopkins W E, Ochoa L L, Richardson G W, Trulock E P. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.  J Heart Lung Transplant. 1996;  15(1 Pt 1) 100-105
• 51 Hopkins W E, Waggoner A D. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome.  Am J Cardiol. 2002;  89 34-38
• 52 Kidd L, Driscoll D, Gersony W et al.. Second natural history study of congenital heart defects. results of treatment of patients with ventricular septal defects.  Circulation. 1993;  87(suppl 2) I38-51
• 53 Jamieson S W, Stinson E B, Oyer P E et al.. Heart-lung transplantation for irreversible pulmonary hypertension.  Ann Thorac Surg. 1984;  38 554-562
• 54 Kramer M R, Marshall S E, Tiroke A, Lewiston N J, Starnes V A, Theodore J. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation.  J Heart Lung Transplant. 1991;  10 317-321
• 55 Levine S M. A survey of clinical practice of lung transplantation in North America.  Chest. 2004;  125 1224-1238
• 56 Kasimir M T, Seebacher G, Jaksch P et al.. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation.  Eur J Cardiothorac Surg. 2004;  26 776-781
• 57 Bando K, Armitage J M, Paradis I L et al.. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1994;  108 1056-1065
• 58 Boujoukos A J, Martich G D, Vega J D, Keenan R J, Griffith B P. Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema.  J Heart Lung Transplant. 1997;  16 439-448
• 59 Ueno T, Smith J A, Snell G I et al.. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome.  Ann Thorac Surg. 2000;  69 381-387
• 60 Mendeloff E N, Meyers B F, Sundt T M et al.. Lung transplantation for pulmonary vascular disease.  Ann Thorac Surg. 2002;  73 209-217 discussion 17-19
• 61 Chapelier A, Vouhe P, Macchiarini P et al.. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension.  J Thorac Cardiovasc Surg. 1993;  106 299-307
• 62 Whyte R I, Robbins R C, Altinger J et al.. Heart-lung transplantation for primary pulmonary hypertension.  Ann Thorac Surg. 1999;  67 937-941 discussion 41-42
• 63 Franke U F, Wahlers T, Wittwer T et al.. Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension.  Transplant Proc. 2002;  34 2181-2182
• 64 Sharples L D, Tamm M, McNeil K, Higenbottam T W, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors.  Transplantation. 1996;  61 560-566
• 65 Goetzmann L, Scheuer E, Naef R et al.. Psychosocial situation and physical health in 50 patients > 1 year after lung transplantation.  Chest. 2005;  127 166-170
• 66 Gross C R, Savik K, Bolman III R M, Hertz M I. Long-term health status and quality of life outcomes of lung transplant recipients.  Chest. 1995;  108 1587-1593
• 67 TenVergert E M, Essink-Bot M L, Geertsma A, van Enckevort P J, de Boer W J, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study.  Chest. 1998;  113 358-364
• 68 Grossman W. Grossman's Cardiac Catherization, Angiography, and Intervention. 6th ed. Philadelphia, PA; Lippincott Williams and Wilkins 2000
• 69 Moodie D S, Sterba R. Long-term outcomes excellent for atrial septal defect repair in adults.  Cleve Clin J Med. 2000;  67 591-597
• 70 Gersony W M, Rosenbaum M S. Congenital Heart Disease in the Adult. New York, NY; McGraw-Hill 2002
• 71 Wu J C, Child J S. Common congenital heart disorders in adults.  Curr Probl Cardiol. 2004;  29 641-700
• 72 Walker R E, Moran A M, Gauvreau K, Colan S D. Evidence of adverse ventricular interdependence in patients with atrial septal defects.  Am J Cardiol. 2004;  93 1374-1377, A6
• 73 Cherian G, Uthaman C B, Durairaj M et al.. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients.  Am Heart J. 1983;  105 952-957
• 74 Berger F, Vogel M, Kramer A et al.. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery.  Ann Thorac Surg. 1999;  68 75-78
• 75 Horvath K A, Burke R P, Collins Jr J J, Cohn L H. Surgical treatment of adult atrial septal defect: early and long-term results.  J Am Coll Cardiol. 1992;  20 1156-1159
• 76 Gatzoulis M A, Freeman M A, Siu S C, Webb G D, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults.  N Engl J Med. 1999;  340 839-846
• 77 Silversides C K, Siu S C, McLaughlin P R et al.. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients.  Heart. 2004;  90 1194-1198
• 78 Masura J, Gavora P, Formanek A, Hijazi Z M. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.  Cathet Cardiovasc Diagn. 1997;  42 388-393
• 79 Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders.  J Am Coll Cardiol. 2005;  45 505-507
• 80 Chessa M, Carminati M, Butera G et al.. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.  J Am Coll Cardiol. 2002;  39 1061-1065
• 81 Steele P M, Fuster V, Cohen M, Ritter D G, McGoon D C. Isolated atrial septal defect with pulmonary vascular obstructive disease: long-term follow-up and prediction of outcome after surgical correction.  Circulation. 1987;  76 1037-1042
• 82 John Sutton M G, Tajik A J, McGoon D C. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up.  Circulation. 1981;  64 402-409
• 83 Murphy J G, Gersh B J, McGoon M D et al.. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years.  N Engl J Med. 1990;  323 1645-1650
• 84 Andersen M, Lyngborg K, Moeller I, Wennevold A. The natural history of small atrial septal defects: long-term follow-up with serial heart catheterizations.  Am Heart J. 1976;  92 302-307
• 85 Neutze J M, Ishikawa T, Clarkson P M, Calcer A L, Barratt-Boyes B G, Kerr A R. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance.  Am J Cardiol. 1989;  63 327-331
• 86 Kirklin J W, DuShane J W. Indications for repair of ventricular septal defects.  Am J Cardiol. 1963;  12 75-79
• 87 Knauth A L, Lock J E, Perry S B et al.. Transcatheter device closure of congenital and postoperative residual ventricular septal defects.  Circulation. 2004;  110 501-507
• 88 Holzer R, Balzer D, Cao Q L, Lock K, Hijazi Z M. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.  J Am Coll Cardiol. 2004;  43 1257-1263